MODD logo

MODULAR MEDICAL INC

MODDNASDAQ
πŸ† #4607 by market capEarnings Mar 3US Equity
$1.81β–Ό $0.28 (βˆ’13.40%)
Market closed Β· at close
πŸ””
Track MODD
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 13.4%
7dβ–Ό 10.8%
14dβ–² 30.7%
30dβ–² 0.3%
ytdβ–Ό 83.1%
1yβ–Ό 85.9%
🏦Market Cap
$18M
Small Cap
πŸ“ˆRevenue Growth (YoY)
0.0%
Slowing
πŸ“ŠGross Margin
0.0%
Thin
πŸ’΅FCF Margin
0.0%
Thin
βš–οΈP/S Ratio
0.0x
Cheap
Otter Score
β€”
Insufficient data

Trading Snapshot

Day Range
$1.81 – $1.81
52-Week Range
$1.20 – $16.20
Volume (shares)
264
Avg Volume (shares)
β€”
Shares Outstanding
9.7M
Next Earnings
2027-03-03

Fundamentals Snapshot

Annual Revenue
β€”
Last Q Revenue
β€”
P/E Ratio
-0.2
P/S Ratio
0.0x
EPS (TTM)
$-3.45
Dividend Yield
0.00%
Dilution (1yr)
+148.1%
MODD logo

MODULAR MEDICAL INC

MODD
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$28Mβ–² +44.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$28Mβ–² +52.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
5.5Mβ–² +148.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$4Mβ–² +$1M YoY
StockOtter Β· stockotter.space

About MODULAR MEDICAL INC

Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of May 2025

Latest News & Updates

News unavailable.